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BORER, K. T., B. SHAPIRO AND A. I. VINIK. A role for somatostatin in the control of hamster growth. BRAIN RES 
BULL 11(6)663-669, 1983.-Concentrations of somatostatin-like immunoreactivity (SRIF-LI) were measured in cerebral 
cortex, hippocampus, septum-POA, median eminence, gastric antrum, fundus and pancreas in adult female hamsters to 
determine whether changes in somatostatin could be related to increased growth hormone (GH) secretion and somatic 
growth that follow bilateral transections of hippocampus (n= 18; 17 controls). In addition, choline acetyltransferase (CAT) 
activity was measured in the four brain regions in hippocarnpectomized (n= 10) and control hamsters (n= 10) to gain insight 
into the relationship between these two neurotransmitters. Hippocampal transections induced: significant acceleration of 
somatic growth; increased serum GH concentrations; increased concentrations of SRIF-LI in septum-FOA and gastric 
antrum; reduced concentrations of SRIF-LI in hippocampus and pancreas; and reduced CAT activity in the hippocampus. 
These results suggest that somatostatinergic and cholinergic projections to hippocampus via fomix suppress GH and 
somatic growth in adult hamsters and that reduced release of SRIF-LI in the gastric antrum may contribute to the 
acceleration of somatic growth through facilitated nutrient digestion and entry. 
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SUPPRESSION of growth hormone (GH) secretion, of 
nutrient absorption [58,59], and inhibition of feeding [40,43] 
are some of the biological functions of somatostatin (SRIF). 
Thus, basal serum GH concentration rises when somatosta- 
tin action is blocked by active [65] or passive [70] immuniza- 
tion. Immunoneutralization of somatostatin restores the high 
amplitude of GH secretory pulses in rats in which GH re- 
lease has been inhibited by stress [4,71], starvation [67], or 
diabetes [66]. The central site of somatostatinergic suppres- 
sion of GH secretion is uncertain. It is thought that this 
action is mediated by the dense cluster of somatostatinergic 
neurons in the periventricular hypothalamus [27,33] and 
their terminations in the median eminence [5, 18, 21, 22, 29, 
33, 52, 631, but the correlation between the control of GH 
secretion and the SRIF content of the median eminence fol- 
lowing their damage is poor [22]. It is possible that the 
extra-hypothalamic SRIF neurons with terminations in the 
hypothalamus [23,29] or that the hypothalamic SRIF 
neurons with terminations in limbic forebrain [49] play a role 
in the control of GH release. 
As the food passes through the gastrointestinal tract and 
as the nutrients enter into the systemic circulation, SRIF is 
released into the stomach from cells in the gastric antrum 
[58, 61, 621 and fundus 1601 and into the splanchnic circula- 
tion from D cells in pancreatic islets [27, 35, 51, 60, 721. As a 
consequence, nutrient absorption [58,59] and secretion of 
gut hormones [8,9] is suppressed, splanchnic blood flow is 
reduced [6,35], and food consumption is inhibited. 
This evidence suggests that SRIF could influence somatic 
growth by controlling the release of GH from the pituitary as 
well as by controlling the ingestion and the availability of 
nutrients for anabolism. Evidence for such dual involvement 
of SRIF in the control of somatic growth comes from two 
lines of experiments. On one hand, when functional coupling 
of GH secretion and nutrient entry is disturbed by hypophy- 
sectomy, meals no longer elicit SRIF release [78]. On the 
other hand, chronic administration of pharmacologic doses 
of SRIF to rapidly growing animals suppresses growth [16, 
53, 731, but may not represent the biological function of this 
peptide. We sought evidence for such dual role of SRIF in 
the control of somatic growth by looking for changes in 
somatostatin concentration in regions of hamster brain and 
gastrointestinal tract following growth-inducing hippocampal 
transections [ 111. In this model of experimental acceleration 
of growth, there are concommitant increases in the rate of 
ponderal and skeletal growth, in food consumption, and in 
concentrations of serum GH and insulin [ 111. 
We have also measured changes in brain acetylcholine in 
the same animals to gain insight into possible cholinergic- 
somatostatinergic interactions. Both neurotransmitters are 
affected in Alzheimer’s disease [24,25], and there are con- 
flicting data about their interaction in the brain [20,55]. 
METHOD 
Animals and Maintenance 
Female golden hamsters (Mesocricetus aura&s 
Waterhouse) over 10 weeks old and weighing 90-100 g were 
obtained from Engle Laboratory Animals, Farmersburg, IN. 
Animals were housed individually in light (12L: 12D) and 
temperature-controlled rooms (22°C) on a diet of Formulab 
5008 Purina Chow and water ad lib. 
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FIG. 1. Dissection of the hamster brain. Ventral view of the brain. 
Broken lines (right) indicate the location of coronal cuts defining 
cerebral cortex (A), septum-POA (B and C), and median eminence 
(D and E). Horizontal, parasagittal and oblique boundaries of these 
tissue blocks are outlined with broken lines (left) in representative 
histological sections in the indicated planes. Legend: AC-Cerebral 
aqueduct of Sylvius; CA-Anterior Commissure; CM-Mammihary 
Bodies; CO-Optic Chiasm; cp-caudate putamen; LM-Medial 
Lemniscus; F-Columns of the fornix; sm-medial septum; TO- 
optic tract. 
Expcriments 
We determined the tissue concentrations of somatostatin 
(n=35) and choline acetyltransferase (n=20) in hamsters 
which received bilateral hippocampal transection (HT, 
n= 18) and in sham-operated controls (C, n= 17). Experiment 
was done twice; hamsters were killed on postoperative days 
9 (10 HT, 1OC) and 14 (8 HT, 7C). We also determined tissue 
concentrations of gastrin in five regions of hamster gut to 
clarify their correspondence with regions of rat gut. This 
identification seemed warranted because of the subdivision 
of hamster stomach into a forestomach and a glandular 
stomach [26] in contrast to the more simple situation in the 
monogastric rat. We also determined serum GH concentra- 
tions in C and SH animals. 
Hippocampal Transections 
Hamsters were anesthetized with sodium pentobarbital 
(75 mg/kg IP). Dorsal hippocampus was transected [II] on 
both sides of the brain with a retractable wire microen- 
cephalotome in a plane perpendicular to its long axis. With the 
skull horizontal between bregma and lamda, the retracted 
knife was positioned 2.8 mm posterior to bregma and 0.5 mm 
lateral to midline. The knife was lowered 3.5 mm below dura. 
extended to a length 3.1-3.5 mm at a 45” angle in the anterio- 
lateral direction and raised to the surface. Sham surgery fol- 
lowed identical procedure except that the knife was lowered 
0.5 mm below dura. 
Animals were sacrificed by decapitation during the sec- 
ond hour of daylight. Blood was collected into chilled tubes. 
Serum was stored at -20°C for subsequent determination of 
FIG. 2. Dissection of hamster upper gastrointestinal tract. Legend: 
A-Annum; B-Body; C-Cardia: D--Duodenum; E-Esophagus; 
FO-Forestomach; FU-Fundus: S---Spleen: HP-Head of Pan- 
creas; TP-Tail of Pancreas. 
growth hormone concentrations. ‘She body and the head 
were kept on ice. The brain was rapidly removed onto a slab 
of aluminum maintained at 2°C. 
Bruin Ti.ss~cc.s 
The brain was dissected by a modification of the tech- 
nique of Brownstein et uf. 1171. Four regions of the brain 
were collected (Fig. 1). A 3-mm wide strip of cerebral cortex 
was separated (A) from the corpus callosum by cuts along 
and parallel to the longitudinal fissure bilaterally. The hip- 
pocampus was severed at its transition into dorsal fornix 
and removed distal to the cuts in HT, bilaterally; The 
brain was then placed ventral surface uppermost anddivided 
by a series of coronal cuts. The septum-preoptic area 
(septum-POA) was contained in a block of tissue between 
cuts B (through the anterior third of the ulfactory tubercle) 
and C (through the optic chiasm and anterior commissure), 
lateral cuts passing through the lateral ventricles and a dorsal 
cut placed 1 mm dorsal to the anterior commissure. This was 
then bisected sag&ally. Median eminence was contained in a 
wedge-shaped block of tissue formed by coronal cuts D and E 
and two oblique cuts 1.5 mm to either side of the midline 
meeting at a point halfway between the aqueduct of Sylvius 
and the ventral surface of the brain. Cortex and hippocam- 
pus from one side of the brain, one half of the septum-POA 
and the median eminence were used for determination of 
immunoreactive somatostatin concentration. The~other cor- 
tex, hippocampus, and the other hatf of the septum-POA 
were used for determination of choline acetyltransferase 
concentration. 
Gustrointestinal Tissues 
The viscera were dissected (Fig. 2) to provide samples of 
gastric fundus, antrum and pancreas. An additional eight un- 
operated animals were dissected to provide samples of 
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TABLE 1 
TISSUE CONCENTRATIONS OF IMMUNOREACTIVE GASTRIN AND SOMATOSTATIN IN THE 
UPPER GASTROINTESTINAL TRACT OF THE GOLDEN HAMSTER (n=S) 
Gas&in-L1 
(pgimg Wet Weight) 
SRIF-LI 
(pg/mg Wet Weight) 
SRIF-LI 
(pgbg Protein) 
Esophagus 15.6 + 3.4* 4.3 + 2.9 0.031 t 0.061 
Forestomach 7.3 2 1.9 0.0 2 0.0 0.00 2 0.00 
Fundus 54.1 k 28.9 2418.9 + 405.8 17.361 2 2.950 
Body of stomach 21.1 * 15.1 1986.9 ? 325.0 14.415 5 2.089 
Antrum 179.4 2 15.1 156.9 + 45.9 1.316 t 0.380 
*Mean + S.E.M. 
esophagus, forestomach, gastric fundus, body, and antrum 
for determinations of gastrin and somatostatin concentra- 
tion. 
Sample Preparation 
All tissue samples were wrapped in pre-weighed pieces of 
aluminum foil, rapidly frozen in solid CO, and weighed on a 
Cahn torsion electrobalance (Cahn Instruments, Cerritos, 
CA). 
For somatostatin and gastrin determinations, tissues were 
homogenized 24 hr after tissue collection in 2 ml of 2 M 
acetic acid, immersed in a boiling water bath for 10 minutes 
to inactivate proteolytic enzymes and rehomogenized. Four 
ml of 2 M acetic acid was added to all homogenates for a final 
volume of 6 ml except for the median eminence which was 
adjusted to a final volume of 3 ml. The tissue homogenates 
were centrifuged at 700 g for 20 minutes. The supernatants 
were stored at -20°C for protein determination [44]. 
For somatostatin determination, aliquots of extracts were 
lyophilized and reconstituted to the original volume in assay 
buffer, immediately before assay. 
Assays 
Somatostatin-like immunoreactivity (SRIF-LI) was 
measured by radioimmunoassay [75,76] utilizing an 
antiserum raised in rabbits to synthetic cyclic SRIF 1-14 
conjugated to whelk hemocyanin by the carbodiimide reac- 
tion. This antiserum (1374 Cape Town) was used in a dilution 
of 1:4000 and has been shown to be specific for the 6-l 1 
region of SRIF l-14. It had 75% crossreactivity with SRIF 
l-25, and 60% crossreactivity with SRIF l-28. The label 
used was ““I-Tyr-I-SRIF prepared by the chloramine-T 
iodination, and purified by chromatography on a CM 52 cel- 
lulose ion exchange column. The specific activity was ap- 
proximately 750 Ci/mole. The standard reference prepara- 
tion was synthetic cyclic SRIF 1-14 (Ayerst AY 24910, 
Ayerst Laboratory, Rouses Point, NY). The assay was per- 
formed in 50 mM ammonium acetate buffer at pH 5.6. Sep- 
aration of antibody-bound from free labeled somatostatin 
was achieved by the use of dextran-coated charcoal. The 
assay had an interassay coefficient of variation of 12% and an 
intraassay coefficient of variation of 5% with a limit of sen- 
sitivity (2 standard deviations above the assay buffer control 
tubes) of 2 pg/tube. Tissue extracts were assayed in multiple 
dilutions in triplicate to determine the parallelism of extrac- 
ted SRIF-LI with the standard curve. To determine re- 
covery of somatostatin, each tissue was bisected along the 
sagittal plane and 400 ng of synthetic SRIF 1-14 was added 
to one half of the tissue prior to homogenization and deter- 
mination of SRIF concentrations. 
Gastrin-LI was determined by radioimmunoassay 
(Becton-Dickinson Co., Orangeburg, NY) using an antibody 
raised in rabbits in a dilution of l:lOO,OOO. This antiserum 
recognized all forms of gastrin [7]. Synthetic heptadecapep- 
tide gastrin was used for standard and was labeled with lz51 
by the chloramine T method for tracer. Separation of bound 
from free tracer was achieved by the use of an ion exchange 
resin (Amberlite CG4B). The level of sensitivity was 1.6 
pg/tube and the intra-assay coefftcient of variation was 5%. 
For choline acetyltransferase determination by the 
method of Fonnum 1291, tissues were homogenized at 1:50 
dilution in 0.5% Triton in 10 mM EDTA, pH 7 [29]. Growth 
hormone concentration was measured with a homologous 
radioimmunoassay for hamster GH [ 151. 
Data Analysis 
Ponderal growth rate was determined with least-squares 
linear regression of weight as a function of time. Student’s 
t-test (two tailed) was used to evaluate differences between 
experimental groups. To normalize GH distribution, statisti- 
cal analysis was performed on logarithmic transformation of 
the data. 
RESULTS 
The recovery of synthetic SRIF-LI 1-14 after the extrac- 
tion procedure was 90.4*8.40/o, and the data were not cor- 
rected to account for the percent of recovery. In all in- 
stances, SRIF-LI in tissue extracts diluted in parallel with 
the SRIF-LI 1-14 standard. A comparison of SRIF-LI and 
gastrin-LI in the upper gastrointestinal tract is presented in 
Table 1. Concentration of gastrin-LI was highest in the 
antrum. The fundus and body of stomach had 13 to 50 times 
more somatostatin than the antrum. There was about 50 to 
200 times less somatostatin in the median eminence of 
sham-operated hamsters as compared to the values usually 
found in the ME of rats [2, 17, 23, 50, 68, 691. 
Hippocampal cuts induced significant acceleration of 
somatic growth as reflected in four-fold increase in the rate 
of ponderal growth in the lesioned hamsters relative to the 
values obtained from the sham-operated animals (2.1kO.2 
vs. 0.5kO.2 g/day, p<O.OOl). Serum GH concentration was 
six times higher in lesioned than in sham-operated hamsters 
(36.2+ 12.3 VS. 6.5? 1.0 r&ml, p<O.Ol). Hippocampal tran- 
sections induced a significant 3% depletion of hippocampal 
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TABLE 2 
CONCENTRATION OF SRIF-LI IN REGIONS OF THE HAMSTER BRAIN AND GUT FOLLOWlhCi 
HIPPOCAMPAL TRANSECTIONS (n=18) OR SHAM SURGERY (n=l7) 
-- 
(pgimg wet weight) tpgifig protein! 
Hippocampal Sham Hippocampal “;ham 
transection surgery transection surgery 
Cerebral cortex 185.4 ‘- 28.0% 161.0 t 22.3 1.7 r 0.3 I 3 0.2 
Hippocampus 247.5 + 30.1 406.0 r 58.0” 2.6 + 0.3 4.3 j 0.5.:. 
Septum-POA 470.3 + 36.1 319.8 -c 42.75. 3.9 k 0.3 3.3 1j.1 
Median eminence 506.9 f 82.6 414.3 r 39.5 4.4 L 0.9 18 II.4 
Antrum 54.6 -+ 6.1 34.7 2 3.7.; 0,s + 0. I ri.3 ll.fjZ” 
Fundus 714.0 f 102.3 899.4 2 96.2 6.6 + I.2 55 0 - 
Pancreas 151.6 k 25.4 256.8 + 35.7:!1 1.0 + 0.1 , 7 ti.;; 
--.. ._-- 





CONCENTRATION OF CHOLINE ACETYLTRANSFERASE IN REGIONS OF THE HAMSTER BRAIN 




(pM/mg wet weight) 
Hippocampal Sham 
transection surgery 
2302.6 t I Il.2:i: 2456.1 i III.9 
556.2 T 92.6 3105.8 i 100.5* 




20.1 + 1.6 22.0 r I.1 
5.3 _f 0.9 28.0 I 1.0+ 
51.8 i 7.4 49.9 d- 5.0 
fMean t S.E.M. 
*p<o.o1. 
tp<o.o01. 
somatostatin (Table 2) and 82% depletion of hippocampal 
acetylcholine (Table 3). Hippocampal transection induced an 
accumulation of SRIF-LI in septum-PGA (Table 2). Fur- 
thermore, there was a significant accumulation of SRIF-LI in 
the antrum and depletion of SRIF-LI from the pancreas 
(Table 2). 
DISCUSSION 
In this study we have investigated a possible role of 
somatostatin in the control of hamster growth through con- 
current suppression of GH secretion and nutrient entry from 
the gastrointestinal tract. We found that the acceleration of 
somatic growth by bilateral hippocampal transection which 
involves increased skeletal growth, increased serum GH and 
insulin concentrations, and transient increase in food con- 
sumption [ 111, is associated with regional changes in SRIF- 
LI concentration in the hamster brain and gastrointestinal 
tract. 
Growth-inducing hippocampal transections were associ- 
ated with a significant depletion of hippocampal SRIF-LI, an 
accumulation of SRIF-LI in septum-POA, and no change in 
the SRIF-LI concentration in the median eminence (Table 2). 
This pattern of change in cerebral SRIF-LI concentration 
following growth-inducing hippocampal transections, has the 
following implications with respect to distribution of SRIF 
fibers in the hamster brain, and their role in the control of 
growth and GH release in the mature hamster. First, there 
appears to be a species difference in the extent of somato- 
statinergic innervation of the median eminence, but not of 
septum (and hippocampus) in the hamster and the rat. We 
found evidence (Table 2) that at least 40% of hippocampal 
SRIF-LI in the hamster is of extra-hippocampal origin and 
arrives to this target via the septum-BOA. Likew~ise, about 
70% of septal SRIF-LI depends on connections ortgmating in 
the periventricular hypothalamus in the rat 148,771. Some of 
the hippocampal SRIF-LI content in the rat is of local origin 
[52]. In contrast to this congruence of SRIF distribution in 
the limbic forebrain in the two species, rat appears to have a 
relatively greater distribution of somatostatinergic fibers 
from the periventricular to the median eminence areas [ 1, 5, 
18, 21, 23, 29, 33, 52, 631 than the hamsterjudging from the 
100 times lower concentration of SRIF-LI in the median 
eminence of the hamster (Table 2) than the values reported 
for the rat [2, 17, 23, 50, 68, 691. 
This distribution difference is paralleled by a similar spe- 
cies difference in the role of SRIF -in the control of GH 
secretion and of somatic growth between the hamster and 
the rat. In the rat, somatostatinergic fibers arriving to 
the median eminence from the periventricular nucleus 
appear to play a role in the suppression of growth, in the 
maintenance of low basal serum GH concentrations 121, 22. 
46, 471, and in the suppression of GH release in response to 
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stress [21,22]. In the hamster, suppression of growth is 
mediated by a septohippocampal neuronal circuit [13, 14, 15, 
161, which includes somatostatinergic fibers with termina- 
tions in hippocampus but not in the median eminence area 
(Table 2). Furthermore, hamster is not likely to have the 
component of SRIF-LI projection to the median eminence 
which suppresses GH secretion in response to stress in the 
rat [4, 21, 22, 69, 711, because it responds to ether stress 
with an increase in GH release [ 151. 
Thus it would appear that the control over GH secretion 
in the hamster is mediated by somatostatinergic innervation 
of the hippocampus and by neurons communicating with 
the median eminence via transmitters other than SRIF-LI. 
Our data imply that somatostatin and acetylcholine may 
act in concert in the control of GH secretion and somatic 
growth in the hamster. Our cuts most probably damage the 
well-known cholinergic projection to hippocampus and cere- 
bral cortex from cells located in medial septum and in the 
brainstem [36,41,42,64]. Acetylcholine has been implicated 
in facilitation of sleep-related GH secretion in the man [45] 
and GH secretion in the rat [74], but conflicting results on the 
interactions between acetylcholine and somatostatin [20,55] 
make it uncertain whether this effect is mediated by 
cholinergic inhibition of somatostatinergic neurons. Our 
findings of parallel depletions of SRIF-LI and acetylcholine 
in hippocampus are in concert with the findings of parallel 
depletions of these two neurotransmitters in the forebrain of 
patients with Alzheimer’s disease [24,25] and prompt further 
experimental scrutiny of the functional relationship between 
these two neurotransmitters. 
Changes in the regional concentration of SRIF-LI in 
hamster gastrointestinal tract during rapid growth suggest 
that this peptide may play a role in nutrient entry in this 
species. We tentatively interpret the increases in antral 
SRIF-LI concentrations as evidence of reduced somatostatin 
release into the antrum and of possible reduced paracrine 
action of this peptide on adjacent [32] gastrin cells. An 
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antagonistic interaction between somatostatin and gastrin 
has previously been shown in the stomach of the rat [56,57]. 
We have also uncovered another apparent species differ- 
ence in the regional distribution of SRIF in this rodent. 
Hamster fundus contains 15 times more SRIF-LI than the 
antrum (Table 1) in contrast to the rat in which SRIF concen- 
tration in the antrum has been reported to be similar to that 
in the fundus [3] or ten times higher [22,38]. We hypothesize 
that high fundic SRIF-LI concentration may have functional 
significance for the control of nutrient transit between the 
forestomach and glandular stomach [26] and for the remark- 
able constancy of hamster meal size and frequency under the 
conditions of variable nutrient need [14]. 
Depletion of pancreatic SRIF-LI in rapidly-growing 
hamsters suggests that lesions induced oversecretion of this 
peptide from pancreatic D cells. This putative oversecretion 
of SRIF may reflect altered pattern of central nervous con- 
trol over pancreatic islets as was reported to occur in rats 
with lesions of the ventromedial hypothalamus [30]. Alter- 
nately, putative oversecretion of pancreatic SRIF may be a 
reactive endocrine reflex to increases in concentration of 
circulating GH [31] or to increased consumption of food 
[34,51]. 
Thus, our data suggest, but do not prove, that in the 
hamster, somatostatin exerts an inhibitory influence over 
GH secretion through nerve terminals innervating the hip- 
pocampus, and over nutrient entry through cells located in 
gastric antrum. 
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